ANKRD52 and neoplasm: Exhausted T cells (LAG3+ PD1+ or TIM3+ PD1+) were also decreased (Supplementary Fig. 5h, i), possibly explaining why Ankrd52 mutation was not eliminated by PD-1 blockade in our tumor mutation profiling (Fig. 1b).